Form 4: John Paulson Increases Stake in Bausch + Lomb
Statement of Changes in Beneficial Ownership
Director John Paulson acquired 15,842 common shares of Bausch + Lomb Corporation through an annual RSU grant.
Summary
- Director John Paulson received an annual grant of 15,842 restricted share units (RSUs).
- The transaction occurred on May 26, 2026, at a valuation of $15.78 per share.
- Following this transaction, the reporting person's total beneficial ownership increased to 89,823 common shares.
- The RSUs are scheduled to vest on the date immediately preceding the next annual meeting of shareholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine regulatory filing reflecting standard director compensation rather than a strategic shift or market-moving event.
Positives
- Director alignment with shareholder interests through increased equity ownership.
- Standardized compensation practice via the 2022 Omnibus Incentive Plan.
Negatives
- None identified; this is a routine director compensation disclosure.
Risks
- Market price volatility affecting the value of equity-based compensation.
Future Outlook
The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Industry Context
StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member incentives with long-term shareholder value, particularly in the pharmaceutical and medical device sectors.
Comparison to Industry Standards
- The grant follows standard equity compensation structures for non-employee directors in large-cap healthcare companies.
- The use of an Omnibus Incentive Plan is consistent with industry benchmarks for executive and director retention.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Annual grant of RSUs under the 2022 Omnibus Incentive Plan. | 05/26/2026 | Standard alignment of director interests with company performance. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation.
Next Steps
- Vesting of RSUs prior to the next annual meeting of shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Date of the RSU grant transaction. |
| 05/28/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Bausch + Lomb, BLCO, John Paulson, Insider Trading, Form 4, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.